Targeting PIM kinase activity significantly augments the efficacy of cytarabine

Kevin R. Kelly, Claudia M. Espitia, Pietro Taverna, Gavin Choy, Swaminathan Padmanabhan, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew

Research output: Contribution to a Journal (Peer & Non Peer)Letterpeer-review

21 Citations (Scopus)
Original languageEnglish
Pages (from-to)129-132
Number of pages4
JournalBritish Journal of Haematology
Volume156
Issue number1
DOIs
Publication statusPublished - Jan 2012
Externally publishedYes

Keywords

  • AML
  • Drug resistance
  • Leukaemia therapy
  • New drug development
  • New drugs for leukaemia

Cite this